Articles written for the GLP list the source as Genetic Literacy Project. All other articles were written for the sources noted with excerpts provided by the GLP.

Controversial treatment for dwarfism meets clinical trial goals. Is FDA approval coming?

A treatment for the most common cause of dwarfism met its goal of increasing height in a pivotal study, the ...
josiah zayner biohacker portrait

Podcast: Talking CRISPR with controversial biohacker Josiah Zayner

Is biohacking a crime? Who came up with the latest CRISPR trick? And did Rage Against the Machine sell out? ...
low libido in young women

Controversial new drug meant to increase sexual desire in women is approved for sale

The Food and Drug Administration approved a controversial drug meant to increase women’s desire for sex, a treatment that has ...
jruhu tlem hcqkrisrsith e xn padcwad dzro

Biohacker Josiah Zayner meets with California regulators investigating him: ‘It was surreal’

A few weeks ago, the prominent biohacker Josiah Zayner took to Instagram to break some news: He had received a ...

Video: Alzheimer’s and the disappointing history of amyloid research

The idea that sticky brain plaques cause Alzheimer’s disease began as an interesting hypothesis and eventually became drug industry dogma. Now, ...
dna tests

Why the results of your genetic ancestry test will change over time

23andMe caused Leonard Kim not one identity crisis but two. The first came in 2016, when Kim, who was raised ...

Fine-tuning CAR-T cancer therapy could eliminate serious side effects, study says

A novel approach to CAR-T cancer therapy promises to upend what has become a truism in medicine: that the treatment’s dramatic effect ...
2-18-2019 jim wilson mini e x

Pioneering ‘refugee’ from gene therapy’s darker days ‘kept the faith’

Gene therapy, now a pillar of biotechnology with the potential to cure deadly diseases, was once a cautionary tale of ...

CRISPR treatment for rare genetic eye disorder gains FDA study approval

Days after a Chinese researcher incensed the world of science with claims of editing the genomes of twin girls, an American ...
dementia x

Small patient pool in Alzheimer’s drug trial casts shadow on positive results

Facing pressing questions about its latest clinical trial in Alzheimer’s disease, Biogen may have sowed further doubt on the future ...

Study sparks fresh debate over an old theory on the cause of Alzheimer’s

In the long-running debate over just what causes Alzheimer’s disease, one side looks to have scored a victory with new ...

Investigational Alzheimer’s drug shows promise

An investigational Alzheimer’s drug significantly slowed patients’ cognitive decline in a large clinical trial, unexpected and unprecedented results that could ...
cancer immunotherapy birak

‘Scientific gold rush’ created by quest for universal immunotherapy

The drug industry has made a mint on immunotherapies for cancer, but those game-changing treatments don’t work for most people’s tumors ...

CRISPRcon talks designer babies and scientific colonialism

While lacking the costuming of Comic-Con or revelry of SantaCon, [CRISPRCon’s] second annual geek-out dealt with a concept weightier than ...
alzheimers disease

Promising Alzheimer’s drug solanezumab fails late-stage trial, hitting dead end

An investigational Alzheimer’s treatment from Eli Lilly failed to slow the progression of the memory-destroying disease in a late-stage trial, ...
Screen Shot at PM

Bombshell health study: Raising HDL “good” cholesterol does not help prevent heart disease

Raising HDL, widely known as good cholesterol, for years has been thought to protect against heart attack and stroke. But ...
SEM Lymphocyte

Turning body’s own defenses to fight tumors: Does CAR-T work?

There’s new hope that a much-hyped class of immunotherapies could revolutionize cancer treatment...But experts remain cautious about safety and efficacy ...
FDA wings

FDA resumes trial using genetically engineered cancer-killing cells two days after patient deaths

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Federal regulators on [July ...

Supreme Court ruling threatens value of many biotech patents

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. On June 27, the ...